If your results are too good, NEJM will reject your paper
Apr 29th 2023 1:01pm EDT
Flavio Cadegiani sent me this slide: Here’s a closer shot of the text (click the image to magnify): Basically, If your results are too good (as in the clinical trial of proxalutamide for treating COVID), NEJM is required to reject your paper even if they can’t find any other problems. CUREUS will reject your paper […]
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.